Trials / Sponsors / Bruno C. Medeiros
Bruno C. Medeiros
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloi Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) | Phase 1 | 2014-12-01 |
| Completed | Phase 2 Study of Temozolomide to Treat Poor Risk / Refractory Acute Myeloid Leukemia Leukemia, Myeloid | Phase 2 | 2007-12-01 |